ALL KEYWORDSHER2-Positive Breast CancerRelated SpecialistsShowing 3 of 32Neal FischbachMDMichael DiGiovannaMD, PhDKathleen FennMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 7QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerBreast CancerA Randomized, Multicenter, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects With Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01)Breast CancerMore Related Clinical Trials
